Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies

Autor: Ziane Bouziane, S., Mans, L., Bucalau, A.-M., Demetter, P., Pezzullo, M., Andre, C., Loi, P., Navez, J., Marcelis, L., Puleo, F., Charette, N., Closset, J., Van Laethem, JL.
Zdroj: In European Journal of Cancer July 2024 206
Databáze: ScienceDirect
Externí odkaz: